selective inhibition bet bromodomains 
epigenetic proteins intently pursued targets ligand discovery far successful efforts limited chromatin modifying enzymes so-called epigenetic writers erasers potent inhibitors histone binding modules yet described report cell-permeable small molecule jq1 binds competitively acetyl-lysine recognition motifs bromodomains high potency specificity towards subset human bromodomains explained co-crystal structures bromodomain extra-terminal bet family member brd4 revealing excellent shape complementarity acetyl-lysine binding cavity recurrent translocation brd4 observed genetically-defined incurable subtype human squamous carcinoma competitive binding jq1 displaces brd4 fusion oncoprotein chromatin prompting squamous differentiation specific antiproliferative effects brd4-dependent cell lines patient-derived xenograft models data establish proof-of-concept targeting protein-protein interactions epigenetic readers provide versatile chemical scaffold development chemical probes broadly throughout bromodomain family 
